Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 5
2000 1
2005 2
2006 3
2008 1
2012 1
2017 3
2018 3
2019 1
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab.
Mehta H, Mashiko S, Angsana J, Rubio M, Hsieh YM, Maari C, Reich K, Blauvelt A, Bissonnette R, Muñoz-Elías EJ, Sarfati M. Mehta H, et al. Among authors: munoz elias ej. J Invest Dermatol. 2021 Jul;141(7):1707-1718.e9. doi: 10.1016/j.jid.2021.01.005. Epub 2021 Jan 30. J Invest Dermatol. 2021. PMID: 33524368 Clinical Trial.
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE).
Eyerich K, Weisenseel P, Pinter A, Schäkel K, Asadullah K, Wegner S, Muñoz-Elias EJ, Bartz H, Taut FJH, Reich K. Eyerich K, et al. Among authors: munoz elias ej. BMJ Open. 2021 Sep 13;11(9):e049822. doi: 10.1136/bmjopen-2021-049822. BMJ Open. 2021. PMID: 34518264 Free PMC article.
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study.
Gordon KB, Armstrong AW, Foley P, Song M, Shen YK, Li S, Muñoz-Elías EJ, Branigan P, Liu X, Reich K. Gordon KB, et al. Among authors: munoz elias ej. J Invest Dermatol. 2019 Dec;139(12):2437-2446.e1. doi: 10.1016/j.jid.2019.05.016. Epub 2019 Jun 15. J Invest Dermatol. 2019. PMID: 31207232 Free article. Clinical Trial.
Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center Stage.
Mehta H, Angsana J, Bissonnette R, Muñoz-Elías EJ, Sarfati M. Mehta H, et al. Among authors: munoz elias ej. Front Immunol. 2021 Jul 14;12:691806. doi: 10.3389/fimmu.2021.691806. eCollection 2021. Front Immunol. 2021. PMID: 34335599 Free PMC article. Review. No abstract available.
Carbon metabolism of intracellular bacteria.
Muñoz-Elías EJ, McKinney JD. Muñoz-Elías EJ, et al. Cell Microbiol. 2006 Jan;8(1):10-22. doi: 10.1111/j.1462-5822.2005.00648.x. Cell Microbiol. 2006. PMID: 16367862 Review.
Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.
Loesche MA, Farahi K, Capone K, Fakharzadeh S, Blauvelt A, Duffin KC, DePrimo SE, Muñoz-Elías EJ, Brodmerkel C, Dasgupta B, Chevrier M, Smith K, Horwinski J, Tyldsley A, Grice EA. Loesche MA, et al. Among authors: munoz elias ej. J Invest Dermatol. 2018 Sep;138(9):1973-1981. doi: 10.1016/j.jid.2018.03.1501. Epub 2018 Mar 17. J Invest Dermatol. 2018. PMID: 29559344 Free article. Clinical Trial.
Nasopharyngeal Exposure to Streptococcus pneumoniae Induces Extended Age-Dependent Protection against Pulmonary Infection Mediated by Antibodies and CD138+ Cells.
Bou Ghanem EN, Maung NHT, Siwapornchai N, Goodwin AE, Clark S, Muñoz-Elías EJ, Camilli A, Gerstein RM, Leong JM. Bou Ghanem EN, et al. Among authors: munoz elias ej. J Immunol. 2018 Jun 1;200(11):3739-3751. doi: 10.4049/jimmunol.1701065. Epub 2018 Apr 16. J Immunol. 2018. PMID: 29661828 Free PMC article.
25 results